Literature DB >> 8633025

Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma.

Y Osono1, L A Woollett, K R Marotti, G W Melchior, J M Dietschy.   

Abstract

High density lipoproteins (HDLs) play a role in two processes that include the amelioration of atheroma formation and the centripetal flow of cholesterol from the extrahepatic organs to the liver. This study tests the hypothesis that the flow of sterol from the peripheral organs to the liver is dependent upon circulating HDL concentrations. Transgenic C57BL/6 mice were used that expressed variable amounts of simian cholesteryl ester-transfer protein (CETP). The rate of centripetal cholesterol flux was quantitated as the sum of the rates of cholesterol synthesis and low density lipoprotein-cholesterol uptake in the extrahepatic tissues. Steady-state concentrations of cholesterol carried in HDL (HDL-C) varied from 59 to 15 mg/dl and those of apolipoprotein AI from 138 to 65 mg/dl between the control mice (CETPc) and those maximally expressing the transfer protein (CETP+). There was no difference in the size of the extrahepatic cholesterol pools in the CETPc and CETP+ animals. Similarly, the rates of cholesterol synthesis (83 and 80 mg/day per kg, respectively) and cholesterol carried in low density lipoprotein uptake (4 and 3 mg/day per kg, respectively) were virtually identical in the two groups. Thus, under circumstances where the steady-state concentration of HDL-C varied 4-fold, the centripetal flux of cholesterol from the peripheral organs to the liver was essentially constant at approximately 87 mg/day per kg. These studies demonstrate that neither the concentration of HDL-C or apolipoprotein AI nor the level of CETP activity dictates the magnitude of centripetal cholesterol flux from the extrahepatic organs to the liver, at least in the mouse.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633025      PMCID: PMC39496          DOI: 10.1073/pnas.93.9.4114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Correlation of low and high density lipoprotein binding in vivo with rates of lipoprotein degradation in the rat. A comparison of lipoproteins of rat and human origin.

Authors:  H R Koelz; B C Sherrill; S D Turley; J M Dietschy
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

2.  Measurement of rates of cholesterol synthesis using tritiated water.

Authors:  J M Dietschy; D K Spady
Journal:  J Lipid Res       Date:  1984-12-15       Impact factor: 5.922

3.  Heterogeneous distribution of filipin--cholesterol complexes across the cisternae of the Golgi apparatus.

Authors:  L Orci; R Montesano; P Meda; F Malaisse-Lagae; D Brown; A Perrelet; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

4.  High-density lipoproteins: epidemiologic profile and risks of coronary artery disease.

Authors:  W B Kannel
Journal:  Am J Cardiol       Date:  1983-08-22       Impact factor: 2.778

5.  Absolute rates of cholesterol synthesis in extrahepatic tissues measured with 3H-labeled water and 14C-labeled substrates.

Authors:  J M Andersen; J M Dietschy
Journal:  J Lipid Res       Date:  1979-08       Impact factor: 5.922

6.  Rates of sterol synthesis and uptake in the major organs of the rat in vivo.

Authors:  S D Turley; J M Andersen; J M Dietschy
Journal:  J Lipid Res       Date:  1981-05       Impact factor: 5.922

7.  Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs.

Authors:  R W Mahley; K H Weisgraber
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

8.  Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat.

Authors:  D K Spady; J M Dietschy
Journal:  J Lipid Res       Date:  1983-03       Impact factor: 5.922

9.  Tissue sites of degradation of apoprotein A-I in the rat.

Authors:  C K Glass; R C Pittman; G A Keller; D Steinberg
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.

Authors:  L A Woollett; Y Osono; J Herz; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more
  18 in total

1.  Is it time to modify the reverse cholesterol transport model?

Authors:  A R Tall; N Wang; P Mucksavage
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

Review 3.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

4.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

5.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

Authors:  YuZhen Zhang; Jaqueline R Da Silva; Muredach Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 6.  Shifting gears: liver SR-BI drives reverse cholesterol transport in macrophages.

Authors:  Astrid E van der Velde; Albert K Groen
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 7.  Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux.

Authors:  Carlos G Santos-Gallego; Chiara Giannarelli; Juan José Badimón
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

8.  Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

Authors:  John S Millar; Gissette Reyes-Soffer; Patricia Jumes; Richard L Dunbar; Emil M deGoma; Amanda L Baer; Wahida Karmally; Daniel S Donovan; Hashmi Rafeek; Laura Pollan; Junichiro Tohyama; Amy O Johnson-Levonas; John A Wagner; Stephen Holleran; Joseph Obunike; Yang Liu; Rajasekhar Ramakrishnan; Michael E Lassman; David E Gutstein; Henry N Ginsberg; Daniel J Rader
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

Review 9.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18

10.  ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.

Authors:  Chonglun Xie; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.